Mitsubishi UFJ Asset Management
LGND icon

Mitsubishi UFJ Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,621
Closed -$193K – 1128
2023
Q1 		$193K Buy
2,621
+244
+10% +$17.3K ﹤0.01% 1028
2022
Q4 		$157K Sell
2,377
-1,193
-33% -$77.6K ﹤0.01% 1049
2022
Q3 		$192K Buy
3,570
+239
+7% +$14K ﹤0.01% 1027
2022
Q2 		$185K Buy
3,331
+918
+38% +$52.1K ﹤0.01% 1049
2022
Q1 		$169K Buy
2,413
+252
+12% +$18.3K ﹤0.01% 1079
2021
Q4 		$204K Sell
2,161
-848
-28% -$78.3K ﹤0.01% 1083
2021
Q3 		$262K Hold
3,009
– – ﹤0.01% 1024
2021
Q2 		$246K Sell
3,009
-2,403
-44% -$200K ﹤0.01% 1068
2021
Q1 		$515K Buy
5,412
+1,807
+50% +$171K ﹤0.01% 885
2020
Q4 		$224K Buy
3,605
+1,318
+58% +$75.1K ﹤0.01% 942
2020
Q3 		$136K Buy
2,287
+17
+0.7% +$1.16K ﹤0.01% 937
2020
Q2 		$158K Buy
2,270
+292
+15% +$18.5K ﹤0.01% 916
2020
Q1 		$90K Buy
1,978
+288
+17% +$16.3K ﹤0.01% 935
2019
Q4 		$107K Buy
1,690
+137
+9% +$9.15K ﹤0.01% 949
2019
Q3 		$96K Buy
1,553
+285
+22% +$17.9K ﹤0.01% 909
2019
Q2 		$90K Sell
1,268
-34
-3% -$2.5K ﹤0.01% 927
2019
Q1 		$102K Buy
1,302
+159
+14% +$12K ﹤0.01% 872
2018
Q4 		$95K Buy
1,143
+289
+34% +$30.8K ﹤0.01% 859
2018
Q3 		$146K Buy
+854
New +$129K ﹤0.01% 809

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Mitsubishi UFJ Asset Management's LGND Position: Q2 2023 in Review

Mitsubishi UFJ Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2023, closing a stake of 2,621 shares — an estimated $193K sold.

Mitsubishi UFJ Asset Management first reported a position in LGND in Q3 2018 and held it in 19 quarters. The position peaked at $515K in Q1 2021. 204 funds tracked by Wall St. Rank hold LGND as of Q2 2023.

  • Mitsubishi UFJ Asset Management reported no remaining Ligand Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 2,621 Ligand Pharmaceuticals shares in Q2 2023, an estimated $193K.
  • Mitsubishi UFJ Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 19 quarters.
  • Mitsubishi UFJ Asset Management's Ligand Pharmaceuticals position peaked at $515K in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.